Open Access. Powered by Scholars. Published by Universities.®
Biomedical Engineering and Bioengineering Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Publication
Articles 1 - 2 of 2
Full-Text Articles in Biomedical Engineering and Bioengineering
High Power, Low Frequency Ultrasound: Meniscal Tissue Interaction And Ablation Characteristics, Brendan O'Daly, Edmund Morris, Graham Gavin, Conor Keane, John O Byrne, Garrett Mcguinness
High Power, Low Frequency Ultrasound: Meniscal Tissue Interaction And Ablation Characteristics, Brendan O'Daly, Edmund Morris, Graham Gavin, Conor Keane, John O Byrne, Garrett Mcguinness
Articles
Abstract—This study evaluates high power low frequency ultrasound transmitted via a flat vibrating probe tip as an alternative technology for meniscal debridement in the bovine knee. An experimental force controlled testing rig was constructed using a 20 kHz ultrasonic probe suspended vertically from a load cell. Effect of variation in amplitude of distal tip displacement (242–494 mm peak-peak) settings and force (2.5–4.5 N) on tissue removal rate (TRR) and penetration rate (PR) for 52 bovine meniscus samples was analyzed. Temperature elevation in residual meniscus was measured by embedded thermocouples and histologic analysis. As amplitude or force increases, there is a …
Perforation Of Arterial Tissue Using Kilohertz Frequency Ultrasound Delivered Via Wire Waveguides, Mark Wylie, Garrett Mcguinness, Graham Gavin
Perforation Of Arterial Tissue Using Kilohertz Frequency Ultrasound Delivered Via Wire Waveguides, Mark Wylie, Garrett Mcguinness, Graham Gavin
Conference Papers
An emerging technology proposes the use of low frequency-high power ultrasound transmitted via wire waveguides for the disruption and ablation of atherosclerotic lesions, more specifically advanced fibrous or calcified plaques such as chronic total occlusions (CTO). This energy delivery selectively ablates rigid diseased tissue by means of direct mechanical contact, cavitation and other forces generated by the intense dynamic pressure fields generated.
The first clinical device using this energy delivery was granted FDA approval in 2007 [1] for the ablation of CTOs and most research to date has focused on ablation and disruption of hard, fibrous or calcified tissues [2]. …